Clinical predictors of head-up tilt test outcome during the nitroglycerin phase
- 132 Downloads
Nitrate-stimulated head-up tilt testing (HUT) is currently recommended to confirm the diagnosis of vasovagal syncope in subjects with syncope of unknown origin. Given the few data currently available, the aim of this study was to assess correlations between nitrate-induced HUT outcomes and the clinical characteristics of patients.
Two hundred and thirty consecutive, otherwise healthy subjects with a history of recurrent unexplained syncope underwent HUT. After 10 min supine rest, they were tilted to 70°, and the test was potentiated by the administration of 300 μg of nitroglycerin after 20 min.
Out of 178 subjects who underwent nitroglycerin administration during HUT, 95 fainted. At univariate Cox regression analysis, a reduced probability of VVS occurrence after nitrates was associated with greater systolic blood pressure and body mass index values, to male gender and smoking. At multivariate Cox regression analysis, only male gender (HR = 0.61; P = 0.039) and smoking (HR = 0.18; P = 0.001) remained significantly associated with HUT outcomes during the pharmacological phase of the test.
Smokers and males are less likely to faint after nitrate administration during HUT than non-smokers and females. Further studies should clarify the possibility of improving the diagnostic power of HUT in these patients.
KeywordsVasovagal syncope Tilt-table testing Nitroglycerin Gender Smoking
This study was partially supported by a grant from the University of Bari. The authors would like to thank Dr. Angela Ferrara, Mr. Cataldo Balducci and Mrs. Margherita Sarlo for their helpful cooperation.
- 2.Aydin MA, Maas R, Mortensen K, Steinig T, Klemm H, Risius T, Meinertz T, Willems S, Morillo CA, Ventura R (2008) Predicting recurrence of vasovagal syncope: a simple risk score for the clinical routine. J Cardiovasc Electrophysiol (Epub ahead of print)Google Scholar
- 4.Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Masotti G, Moya A, Raviele A, Sutton R, Theodorakis G, Ungar A, Wieling W (2004) Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis, treatment) of syncope—update 2004. Europace 6:467–537CrossRefPubMedGoogle Scholar
- 13.Kiowski W, Linder L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, Bühler FR (1994) Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 90:27–34PubMedGoogle Scholar
- 14.Kurbaan AS, Franzén AC, Bowker TJ, Williams TR, Kaddoura S, Petersen ME, Sutton R (1999) Usefulness of tilt test-induced patterns of heart rate and blood pressure using a two-stage protocol with glyceryl trinitrate provocation in patients with syncope of unknown origin. Am J Cardiol 84:665–670CrossRefPubMedGoogle Scholar
- 20.Takase B, Uehata A, Nishioka T, Isojima K, Satomura K, Ohsuzu F, Kurita A (2001) Different mechanisms of isoproterenol-induced and nitroglycerin-induced syncope during head-up tilt in patients with unexplained syncope: important role of epinephrine in nitroglycerin-induced syncope. J Cardiovasc Electrophysiol 12:791–796CrossRefPubMedGoogle Scholar